Integrin-mediated Signaling Events in Human Endothelial Cells by Short, Sarah M. et al.
Molecular Biology of the Cell
Vol. 9, 1969–1980, August 1998
Integrin-mediated Signaling Events in Human
Endothelial Cells
Sarah M. Short,* Gregory A. Talbott,† and Rudolph L. Juliano*‡
*Department of Pharmacology, School of Medicine and †Department of Pediatrics, University of
North Carolina, Chapel Hill, North Carolina 27599
Submitted December 9, 1997; Accepted May 5, 1998
Monitoring Editor: Joan Brugge
Vascular endothelial cells are important in a variety of physiological and pathophysio-
logical processes. The growth and functions of vascular endothelial cells are regulated
both by soluble mitogenic and differentiation factors and by interactions with the extra-
cellular matrix; however, relatively little is known about the role of the matrix. In the
present study, we investigate whether integrin-mediated anchorage to a substratum
coated with the extracellular matrix protein fibronectin regulates growth factor signaling
events in human endothelial cells. We show that cell adhesion to fibronectin and growth
factor stimulation trigger distinct initial tyrosine phosphorylation events in endothelial
cells. Thus, integrin-dependent adhesion of endothelial cells leads to tyrosine phosphor-
ylation of both focal adhesion kinase and paxillin, but not of several growth factor
receptors. Conversely, EGF stimulation causes receptor autophosphorylation, with no
effect on focal adhesion kinase or paxillin tyrosine phosphorylation. Adhesion to fi-
bronectin, in the absence of growth factors, leads to activation of MAPK. In addition,
adhesion to fibronectin also potentiates growth factor signaling to MAPK. Thus, polypep-
tide growth factor activation of MAPK in anchored cells is far more effective than in cells
maintained in suspension. Other agonists known to activate MAPK were also examined
for their ability to activate MAPK in an anchorage-dependent manner. The neuropeptide
bombesin, the bioactive lipid lysophosphatidic acid (LPA), and the cytokine tumor
necrosis factor a, which signal through diverse mechanisms, were all able to activate
MAPK to a much greater degree in fibronectin-adherent cells than in suspended cells. In
addition, tumor necrosis factor a activation of c-Jun kinase (JNK) was also much more
robust in anchored cells. Together, these data suggest a cooperation between integrins
and soluble mitogens in efficient propagation of signals to downstream kinases. This
cooperation may contribute to anchorage dependence of mitogenic cell cycle progression.
INTRODUCTION
The vascular endothelium represents an important
interface between the blood vessel lumen and tissues,
is central to early stages of development, and is in-
volved in the structural and functional regulation of
homeostasis and in tissue perfusion including regula-
tion of vascular tone and permeability (Folkman and
Shing, 1992; Wagner and Risau, 1994). It is also impor-
tant to the processes of wound healing, inflammation,
and angiogenesis (Clark et al., 1982; Folkman, 1992),
and plays a critical role in various disease processes,
such as atherosclerosis, the growth of solid tumors,
and metastasis (Blood and Zetter, 1990; Folkman,
1992, 1995; Ross, 1993). A wide range of factors are
known to regulate endothelial function; these factors
include vasoconstrictors, vasodilators, anticoagulants,
growth factors, and cytokines [basic fibroblast growth
factor (bFGF), vascular endothelial growth factor
(VEGF), TGF-b, and tumor necrosis factor a (TNFa)].
In addition, endothelial cells are influenced by expres-
sion of engagement of adhesion molecules such as the
b1 integrins. Integrin binding, cytoskeletal organiza-
tion, and consequent changes in cell shape are inti-* Corresponding author.
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mately involved in the process whereby cell adhesion
to the extracellular matrix or adjacent cells regulates
endothelial cell migration, proliferation, and differen-
tiation, angiogenesis, and apoptosis (Hynes, 1992;
Juliano and Haskill, 1993; Frisch and Francis, 1994;
Clark and Brugge, 1995; Varner et al., 1995). The ex-
tracellular matrix is required for endothelial cell sur-
vival and proliferation in response to growth factors,
rendering cells apoptotic in the absence of matrix
(Meredith et al., 1993; Re et al., 1994).
Remodeling of blood vessels and the concomitant
reorganization of the cytoskeleton requires the in-
volvement of integrins, which comprise a family of at
least 20 different ab heterodimers in mammals
(Hynes, 1992). In addition to playing a major role in
angiogenesis and apoptosis, integrins are also be-
lieved to be important in maintaining endothelial cell
polarity and in the sensing and responding to changes
in blood vessel flow conditions. Several different
members of the integrin family are expressed on the
surface of endothelial cells, including the receptors for
fibronectin, laminin, and collagen. Different combina-
tions of integrin subunits on the cell surface allow cells
to recognize and respond to a variety of extracellular
matrix proteins under different physiological condi-
tions. For example, the avb1 and a5b1 fibronectin re-
ceptors are highly expressed in quiescent endothelial
cells, whereas the avb3 fibronectin and vitronectin re-
ceptor is expressed only during the process of angio-
genesis (Brooks et al., 1994a). In fact, antagonist block-
ing of avb3 has been shown to induce apoptosis in
proliferating endothelial cells (Brooks et al., 1994b).
Binding of integrins with extracellular matrix pro-
teins is characterized by extracellular domain confor-
mational changes, cytoskeletal reorganization, and in-
tegrin clustering (Burridge et al., 1988; Loftus et al.,
1994). In many cell types, clustering of integrins leads
to formation of focal adhesion complexes containing
cytoplasmic cytoskeletal proteins and also provides a
framework for the assembly of catalytic signaling pro-
teins (Burridge et al., 1988; Yamada and Miyamoto,
1995). Integrin ligation has been shown to result in
activation of a variety of cellular signaling pathways
(Rosales et al., 1995). In many cell types, integrin bind-
ing induces tyrosine phosphorylation of specific pro-
teins, including focal adhesion kinase (FAK), a cyto-
plasmic nonreceptor tyrosine kinase, and paxillin, an
adapter protein (Burridge et al., 1992; Hanks et al.,
1992; Schaller et al., 1992). FAK plays a key role in
regulating the dynamic changes in actin cytoskeleton
organization that are a prerequisite for cell migration.
The tyrosine phosphorylation of FAK is stimulated by
b1 and b3 integrins (Guan and Shalloway, 1992;
Huang et al., 1993; Ishida et al., 1996), as well as by
numerous regulatory peptides and lipids acting on G
protein-coupled receptors (Zachary et al., 1993;
Seufferlein and Rozengurt, 1994). Paxillin, a 68-kDa
protein that colocalizes to focal adhesions (Burridge et
al., 1992), has been shown to associate with FAK and is
a putative substrate for FAK (Turner et al., 1993; Hilde-
brand et al., 1995).
Although integrins show no intrinsic protein kinase
activity (Hynes, 1992), their engagement activates sig-
nal-transducing molecules usually associated with
growth factor stimulation, including protein kinases,
inositol lipid kinases, G proteins, and the Na1/H1
antiporter (Ingber et al., 1990; Guan et al., 1991; Guan
and Shalloway, 1992; Kornberg et al., 1992; Schwartz
and Lechene, 1992; Kapron-Bras et al., 1993; Chen and
Guan, 1994; Chen et al., 1994; Schlaepfer et al., 1994).
Accumulating evidence demonstrates overlap be-
tween signals generated by integrins and the consen-
sus Ras-signaling pathway triggered by receptor ty-
rosine kinases that is important in cell proliferation
and differentiation (Chen et al., 1994; Schlaepfer et al.,
1994; Zhu and Assoian, 1995). Similar to stimulation of
tyrosine kinase receptors, integrin-mediated cell adhe-
sion has been shown to activate MAPK, a key down-
stream effector of the Ras-signaling pathway (Chen et
al., 1994). However, in fibroblasts, recent studies show
that FAK activation and integrin-mediated MAPK ac-
tivation are independent events (Lin et al., 1997a,b).
Since integrins stimulate many of the same signal
transduction events as growth factors, including phos-
phorylation and activation of MAPK, numerous labo-
ratories have explored the possibility that integrins
and growth factors might function cooperatively with
respect to MAPK activation (Assoian, 1997; Renshaw
et al., 1997; Schwartz, 1997). Most of the studies thus
far have been performed in fibroblasts. However,
there have also been valuable studies concerning in-
tegrin regulation of ionic transients and of polyphos-
phoinositide levels in endothelial cells (Ingber et al.,
1990; McNamee et al., 1993; Chong et al., 1994). Thus, it
seems important to further develop our understand-
ing of integrin regulation of signaling processes in
vascular endothelial cells.
It has become increasingly apparent that, like recep-
tor protein tyrosine kinases, G protein-coupled recep-
tors and G proteins are also involved in the regulation
of cell growth and differentiation (Pace et al., 1995;
Della Roca et al., 1997). Many of these effects are me-
diated through the MAPK-signaling cascade. How-
ever, the coupling mechanisms between G protein-
linked receptors and the MAPK kinase cascade are
still poorly characterized. Interestingly, tyrosine phos-
phorylation has recently been implicated in the action
of neuropeptide and bioactive lipids that act as cellu-
lar growth factors through G protein-coupled recep-
tors (Rozengurt, 1995; Della Roca et al., 1997). Very
little is known about what role integrins might play in
the regulation of G protein-coupled receptor signaling
to MAPK. Cytokine signaling is also important in the
biology of endothelial cells, with TNFa playing a par-
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ticularly important role. The signaling pathways
downstream of TNF are very complex (Liu et al., 1996)
and have not, to our knowledge, been investigated
from the point of view of anchorage dependence.
In the present study, we examined whether integrin-
mediated anchorage regulates growth factor-signaling
events in human endothelial cells. We report that an-
chorage of endothelial cells to a fibronectin substra-
tum is sufficient to induce FAK and paxillin tyrosine
phosphorylation, but tyrosine kinase receptors are not
autophosphorylated. Conversely, treatment with
polypeptide growth factors is able to induce receptor
phosphorylation, independent of adhesion to a matrix.
However, we demonstrate a cooperation between in-
tegrins and soluble polypeptide growth factors in the
activation of MAPK. In addition, we find that activa-
tion of MAPK by bombesin, lysophosphatidic acid, or
TNFa is also anchorage dependent.
MATERIALS AND METHODS
Immunological Reagents
All antibodies used against integrin subunits were anti-human
mouse monoclonals (Life Technologies, Gaithersburg, MD). Mouse
mAbs against FAK (clone 2A7) and anti-phosphotyrosine (clone
4G10) antibody were from Upstate Biotechnology (Lake Placid, NY);
anti-paxillin (clone 349) was obtained from Transduction Laborato-
ries (Lexington, KY). Antibody to the active phosphorylated forms
of p42/p44 MAPK was purchased from Promega (Madison, WI).
Antibodies against p42 (MAPK2, sc-154), MAPKs 1 and 2 (sc-93),
and JNK1 (sc-474) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Polyclonal rabbit antibody against the EGF-recep-
tor was from Upstate Biotechnology. R-phycoerythrin-conjugated
secondary antibodies and either FITC- or TRITC-conjugated second-
ary antibodies were obtained from Sigma (St. Louis, MO). Myelin
basic protein (MBP) was purchased from Life Technologies, Inc.,
and c-Jun–GST fusion protein was prepared by A. Aplin (University
of North Carolina Chapel Hill). Protein G-Sepharose 4 Fast Flow
was purchased from Pharmacia Biotech (Piscataway, NJ).
[g-32P]ATP (3000 Ci/mmol) was obtained from DuPont/New En-
gland Nuclear (Wilmington, DE). Bombesin was purchased from
Peninsula Laboratories (Belmont, CA). Calyculin A was obtained
from Calbiochem (San Diego, CA). EGF and bFGF were purchased
from Upstate Biotechnology. Recombinant VEGF and TNFa were
kindly provided by Genentech (South San Francisco, CA). All other
reagents and chemicals were purchased from Sigma unless other-
wise indicated.
Endothelial Cell Isolation and Culture, Preparation
of Fibronectin-coated Dishes, and Cell Adhesion
Studies
Primary human umbilical vein cells (HUVECs) were kindly pro-
vided by Dr. Lew Romer (Univeristy of North Carolina, Chapel Hill,
Chapel Hill, NC) and were harvested and maintained as described
previously (Romer et al., 1994). HUVECs were also obtained from
Clonetics (San Diego, CA) and were maintained according to the
supplier’s directions. For experiments, HUVEC cultures were
grown to confluence and used between passages three and four. The
human endothelial cell line ECV304 (American Type Culture Col-
lection, Rockville, MD) was maintained in Medium 199 (Life Tech-
nologies) supplemented with 10% heat-inactivated FBS (HyClone,
Logan, CT) and penicillin (50 units/ml)/streptomycin (50 mg/ml) in
5% CO2/95% air at 37°C. For adhesion studies, 100-mm plastic Petri
dishes were coated with 20 mg/ml fibronectin (Collaborative Re-
search, Bedford, MA) in PBS at 4°C overnight. Dishes were washed
twice with PBS and blocked with 2% BSA in serum-free medium for
1 h at 37°C. Blocking buffer was aspirated and cells were replated on
fibronectin-coated dishes at a cell density of approximately 50%. For
immunofluorescence, cells were fixed in 2% paraformaldehyde and
permeabilized with 0.5% Triton X-100 in PBS. Cells were stained
with an anti-phosphotyrosine mAb to visualize focal contacts or
with rhodamine-labeled phalloidin to visualize actin filaments. Cell
spreading, focal contacts, and stress fibers were observed and re-
corded using an Olympus digital phase-fluorescence microscopy
system.
Flow Cytometry Analysis
Near confluent cells (approximately 4 3 106/185-cm2 flask) were
detached by treatment with 0.05% trypsin/EDTA, washed, counted,
aliquoted (0.5–1 3 106cells/condition) and resuspended in 100 ml of
cold PBS containing 1% BSA (1% BSA/PBS). Cells were incubated
with primary antibodies (2 mg/ml or 10 mg/ml) for 60 min at 4°C,
washed, and incubated with either goat anti-mouse or anti-rabbit
IgG conjugated to R-phycoerythrin (20 mg/ml) for 30 min at 4°C.
Following three washes in 1% BSA/PBS, cells were briefly fixed in
2% paraformaldehyde in PBS, washed, and resuspended in 500 ml of
PBS and analyzed for fluorescence using a flow cytometer (Becton
Dickinson, San Jose, CA). Typically, 2 3 104 cells were analyzed.
Omitting the primary antibody assessed background fluorescence.
For both cell types, the relative fluorescence intensity was expressed
as a percentage of b1 fluorescence.
Cell Treatment, Immunoprecipitation, Western
Blots, and Immune Complex Kinase Assays
Confluent cells were serum starved for 6 h prior to detachment with
0.05% trypsin/0.33 mM EDTA. Trypsin was inactivated with soy-
bean trypsin inhibitor (1 mg/ml), and cells were pelleted and re-
suspended in Medium 199 containing 2% BSA, and rocked for 60
min at 37°C to allow kinases to become quiescent. Cells were
replated on plastic dishes precoated with fibronectin (20 mg/ml)
and incubated at 37°C for the indicated times. Mitogens were added
where indicated for 5 min prior to cell harvest. Cells were washed
three times on ice with cold PBS and lysed in a modified RIPA buffer
containing 50 mM Tris (pH 7.5), 1% Nonidet P-40, 0.1% sodium
deoxycholate, 150 mM NaCl, 50 mM sodium fluoride, 1 mM sodium
pyrophosphate, 1 mM sodium o-vanadate, 1 mM nitrophenolphos-
phate, 5 mM benzamidine, 0.2 mM calyculin A, 2 mM phenylmeth-
ylsulfonyl fluoride, and 10 mg/ml aprotinin. Cells were kept on ice
for 10 min in lysis buffer, and cell lysates were prepared by scraping,
followed by vortexing, and centrifuging for 5 min at 15,000 3 g at
4°C. Cell lysates were stored at 270°C until use. Lysate protein
concentration was determined using the bicinchonic acid assay
(Pierce, Rockford, IL).
For immunoprecipitation cell lysates were incubated with pri-
mary antibody for either 2 h (FAK, MAPK2, and JNK1) or overnight
(for growth factor receptors) at 4°C with rocking, followed by
incubation with protein G-Sepharose for an additional 2 h at 4°C.
Bead complexes were washed three times with cold RIPA buffer
(without added protease inhibitors) and boiled with SDS-PAGE
sample buffer. For immune complex kinase assays, the precipitates
were washed once with cold RIPA buffer and three times with cold
kinase wash buffer (0.25 M Tris, pH 7.5, 0.1 M NaCl). Immunocom-
plexes were incubated for 30 min in a kinase assay buffer (10 mM
Tris, pH 7.5, 10 mM MgCl2, 1 mM DTT, 10 mM ATP, 5 mCi [32P]ATP)
containing either 10 mg of MBP or c-Jun-GST. Reactions were
stopped with the addition of hot 33 SDS sample buffer, boiled for
5 min, and centrifuged. Proteins were electrophoresed on 15%
SDS-polyacrylamide gels, dried, and exposed to x-ray film. The
32P-labeled MBP or c-Jun-GST substrate bands, corresponding to
MAPK and JNK, respectively, were quantitated using a Storm 840
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PhosporImager with Image-Quant software (Molecular Dynamics,
Sunnyvale, CA).
For Western blot analysis, total cell lysates or immunoprecipi-
tated proteins were separated by SDS-PAGE under reducing con-
ditions. Proteins were transferred electrophoretically onto polyvi-
nylidene fluoride membranes (Immobilon P, Millipore Corp.,
Bedford, MA), blocked with 1% BSA/PBS/0.1% Tween 20 for 1 h (or
overnight at 4°C) ,and subsequently incubated with primary anti-
body (1 mg/ml) in 1% BSA/PBS/0.1% Tween 20 for 1 h at room
temperature. Membranes were washed briefly and incubated with
goat anti-mouse IgG or goat anti-rabbit IgG peroxidase conjugates
for 30 min. Following extensive washing, immunoreactivity was
detected on Hyperfilm using ECL (ECL kit, Amersham Corp., Ar-
lington Heights, IL). Images from ECL autoradiograms were cap-
tured using NIH Image and Adobe software.
RESULTS
Cell Morphology and Integrin Subunit Expression in
HUVECs and ECV304 Cells
In this study, we used adhesion to fibronectin to eval-
uate integrin-mediated signaling events in primary
HUVECs and an endothelial cell line, ECV304. We
first examined the morphology of these cells, and eval-
uated their display of integrin subunits at the cell
surface. Morphologically, both the ECV304 cells and
HUVECs grew as contact-inhibited cobblestone mono-
layers; in addition, both cell types displayed well-
developed focal contacts and stress fibers (Figure 1A).
A typical integrin flow cytometry profile is given in
Figure 1B, whereas Table 1 compiles the results of a
survey of several integrin subunits. Several a subunits
known to complex with b1 were expressed, with
HUVECs having relatively higher levels of a5b1, a
fibronectin receptor, while ECV304 cells seemed to
preferentially express a3b1. As expected, av integrins
were also detected, suggesting that the avb1 fibronec-
tin receptor might also be present. Thus, both cell
types displayed typical endothelial cell morphological
characteristics and a number of commonly expressed
integrins, including one or more potential receptors
for fibronectin.
Cell Adhesion and Mitogen Stimulation Trigger
Distinct Initial Tyrosine Phosphorylation Events
Attachment of ECV304 cells to a fibronectin substra-
tum stimulated the tyrosine phosphorylation of sev-
eral protein bands as detected by anti-phosphoty-
rosine blots; the major bands were approximately 125
kDa and 68 kDa (Figure 2A). As reported for other cell
types (Lin et al., 1997a,b), adhesion of endothelial cells
to fibronectin induced tyrosine phosphorylation of
FAK, as seen by both anti-phosphotyrosine blots of
total cell lysates (Figure 2A, top panel) and after im-
munoprecipitation with an anti-FAK antibody (Figure
2C, top panel). Cell adhesion to fibronectin was also
accompanied by tyrosine phosphorylation of the 68-
kDa focal adhesion-associated protein paxillin, a pu-
tative substrate for FAK (Figure 2, A and D). There-
fore, major components of the adhesion-dependent
tyrosine phosphorylated 68-kDa and 125-kDa bands
were identified as paxillin and FAK, respectively. Ty-
rosine phosphorylation of paxillin and FAK was not
modified by EGF stimulation (Figure 2, C and D).
To compare the effects of integrin receptor-mediated
tyrosine phosphorylation events to the known growth
factor tyrosine kinase cascade, we used EGF as an
agonist. Treatment of ECV304 cells with EGF induced
autophosphorylation of the 180-kDa EGF receptor, in-
dependent of adhesion, as seen in both the total cell
lysates (Figure 2A) and in lysates immunoprecipitated
for the EGF receptor (Figure 2B). These results clearly
show that integrin engagement and growth factor
Figure 1. Morphology and integrin expression of ECV304 cells and
HUVECs. (A) Morphology. Cells were maintained in culture as
described in MATERIALS AND METHODS. Fixed, permeabilized
cells were stained for phosphotyrosine to visualize focal contacts
and for actin to visualize stress fibers. (B) Flow cytometry. For the
analysis of integrin expression, viable cells were stained with anti-b1
(top) or anti-a5 (bottom) antibodies. Shaded histograms represent
cells treated with anti-integrin subunit antibodies; open histograms
show the staining of negative controls (no primary antibody). The
ordinate displays cell number, and the abscissa displays relative
fluorescence intensity on an arbitrary scale.
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stimulation are able to trigger a discrete set of early
signaling events.
MAPK and FAK Are Activated by Adhesion to
Fibronectin
Integrin-dependent adhesion of ECV304 cells to a fi-
bronectin-coated substratum leads to rapid activation
of the cytoplasmic serine/threonine kinase MAPK.
Using an antibody specific for the activated phosphor-
ylated forms of MAPK, we show that adhesion to
fibronectin increased levels in both the p42 and p44
forms of MAPK (MAPK 1 and 2, respectively). How-
ever, in ECV304 cells, the activation of the 42-kDa
form of MAPK was consistently more prominent than
the p44 form. Both the p42 and p44 isoforms of MAPK
are present in ECV304, with p42 being more abundant
(Figure 3A, bottom panel). Integrin-mediated activa-
tion of MAPK was transient and showed a maximal
activation at 15–30 min with a gradual decline over a
period of 2–3 h (Figure 3A, top panel). In contrast,
antiphosphotyrosine Western blots of FAK immuno-
precipitates showed FAK tyrosine phosphorylation
with a somewhat delayed, but clearly more sustained,
activity in comparison to the MAPK activation time
course (Figure 3B, top panel). In ECV304 cells, the
maximal activation of MAPK occurred with minimal
evidence of cell spreading, whereas the maximal in-
crease in FAK tyrosine phosphorylation appears to be
coincident with cell spreading on fibronectin (Figure
3C).
Cytochalasin D, a drug known to disrupt the actin
cytoskeleton and to interfere with integrin-mediated
activation of MAPK and FAK in fibroblasts, was also
examined in adherent endothelial cells. A 30-min pre-
treatment of ECV304 cells with 1 mM cytochalasin D
largely blocked the activation of both MAPK and FAK
when endothelial cells were plated on fibronectin for
30 min (Figure 3D). MAPK activation was also inhib-
ited at later time points and no MAPK activation was
observed in nonadherent cells (our unpublished re-
sults). Care was taken to obtain a concentration of
cytochalasin D that was not toxic to endothelial cells,
which might have prevented secure adhesion to fi-
bronectin. At all time points, cells were well anchored
Figure 2. Cell adhesion and EGF stimulation trigger distinct initial
tyrosine phosphorylation events in ECV304 cells. Confluent cells
were serum starved for 6 to 8 h, trypsinized, resuspended in 2%
BSA, and rocked in suspension for 1 h. Tyrosine phosphorylation
levels were measured in cells either replated on fibronectin-coated
dishes (Fn) or maintained in nonadherent suspension culture
(NAD) for 2 h. Where indicated (1) EGF (1 ng/ml) was added to
medium 5 min before cell harvest. Samples were Western blotted
with a monoclonal anti-phosphotyrosine antibody and then re-
probed with an antibody to the protein of interest. (A) Total cell
lysates; blotted with anti-P-tyr. (B) lysates immunoprecipitated with
a monoclonal anti-EGF receptor antibody; blotted with anti-P-tyr,
reprobed with anti-EGFR. (C) Immunoprecipitation with an anti-
FAK antibody; blotted with anti-P-tyr, reprobed with anti-FAK. (D)
Immunoprecipitation with an anti-paxillin antibody, blotted with
anti-P-tyr, reprobed with anti-paxillin.
Table 1. Integrin subunit expression in ECV304 cells and HUVECs
Integrin subunit









Cells (0.5 3 106) were incubated with primary antibodies, washed,
incubated with an anti-mouse IgG conjugated to R-phycoerythrin,
fixed, and analyzed for fluorescence using a flow cytometer. The
relative fluorescence intensity is expressed as a percentage of b1
fluorescence.
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to the fibronectin substratum, but with no evidence of
cell spreading (our unpublished results). This indi-
cates that a degree of organization of the actin cy-
toskeleton is essential to both FAK and MAPK activa-
tion triggered by endothelial cell adherence.
Growth Factor Activation of MAPK Requires
Adhesion to Fibronectin
Despite the fact that growth factors and integrins
show distinct initial tyrosine phosphorylation pat-
terns, several studies have reported on the conver-
gence of integrin- and growth factor-mediated signal-
ing at the level of MAPK (Miyamoto et al., 1996; Lin et
al., 1997b; Renshaw et al., 1997). We also investigated
whether polypeptide growth factor activation of
MAPK was anchorage dependent in endothelial cells.
Western blotting of ECV304 lysates with an antibody
specific for the phosphorylated forms of MAPK shows
that a 5-min treatment of ECV304 cells with EGF in-
duced rapid and concentration-dependent activation
of MAPK (Figure 4A). This activation of MAPK was
observed in cells that were plated on fibronectin for
3 h. EGF concentrations as low as 0.2 ng/ml were
sufficient to activate MAPK under adherent condi-
tions, with maximal activation observed between 20
and 100 ng/ml. In contrast, cells maintained under
Figure 3. Adhesion to fibronectin activates both MAPK and FAK tyrosine phosphorylation: relationship to cell spreading and cytoskeletal
organization. Confluent ECV304 cells were serum starved for 6 to 8 h. Detached cells were suspended in medium containing 2% BSA.
Following a 1-h period in suspension, cells were allowed to attach to dishes coated with fibronectin (Fn). For nonadherent conditions, cells
were held in suspension (NAD). At the intervals indicated, cells were lysed and analyzed by Western blot analysis for MAPK activation (A)
and FAK tyrosine phosphorylation (B) from FAK immunoprecipitates (top panels, A and B). Parallel blots were probed with either a
polyclonal anti-MAPK or a polyclonal anti-FAK antibody to show equal loading (bottom panels, A and B). (C) Phase-contrast micrographs
of cells after 10 and 60 min on fibronectin show cell attachment at the early time point and attachment and spreading at the later time point.
(D) Cells were pretreated with cytochalasin D (Cyto D, 1 mM) for 20 min prior to replating on fibronectin for 30 min and analyzed for both
MAPK activation (top panels) and FAK tyrosine phosphorylation (bottom panels).
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nonadherent conditions displayed only a minimal
MAPK activation at low doses of EGF, with no signif-
icant increases at 100 ng/ml of EGF (Figure 4A). As
seen with direct adhesion-mediated activation of
MAPK, treatment with EGF in adherent cells predom-
inantly activated the p42 form of MAPK. These results
show that integrin engagement is able to modulate
EGF-mediated MAPK activation, as evidenced by an
increased maximal response.
We next evaluated the time dependence of growth
factor-stimulated MAPK activation in endothelial cells
plated on a fibronectin substratum. Similar to the re-
sults shown in Figure 3A, endothelial cells show a
transient adhesion-dependent MAPK activation when
plated on a fibronectin substratum (Figure 4B, lanes
without EGF). The time course of EGF effects on
MAPK activation was also evaluated. At early time
points (10–30 min), EGF stimulation had minimal ad-
ditional effects on the adhesion-induced activation of
MAPK. However, as the transient adhesion-mediated
MAPK activation decreased to basal levels (between
60 and 180 min), treatment with a low dose of EGF (1
ng/ml) provided a strong MAPK activation (Figure
4B, lanes with EGF). We also examined the effect of
longer periods in suspension on the collaboration be-
tween cell adhesion and mitogen signaling. Cells held
in suspension for 15 min, 3 h, and 6 h and then
replated on fibronectin-coated dishes showed similar
results to the 1-h point (Figure 4B); treatment with
EGF showed adhesion-dependent activation of MAPK
(our unpublished results).
Primary endothelial cells were also investigated for
anchorage dependence of growth factor activation of
MAPK. HUVECs showed a strong, transient activa-
tion of MAPK when plated on a fibronectin substra-
tum in the absence of growth factors (Figure 5A).
These results are consistent with our results using the
endothelial cell line ECV304. However, in HUVECs,
the maximal activation of MAPK appears to be more
robust, with very low basal levels of activated MAPK
(Figure 5A, 0 min and 180 min in suspension). We
have noticed that there is relatively little p44 in
ECV304s and a somewhat lower amount of p44 than
p42 in HUVECs; this is reflected in a weaker signal in
the p44 level upon cell adhesion. As with the cell line,
HUVECs also display an anchorage dependence of
growth factor activation of MAPK (Figure 5B). Thus,
both bFGF and VEGF show strong anchorage depen-
dence of MAPK activation (Figure 5B), as does EGF
(our unpublished results). Although HUVECs also
predominantly activate the p42 phosphorylated form
of MAPK, they do show the p44 phosphorylated form
when either maximally activated by adhesion (Figure
5A, 10 min) or stimulated with mitogen under adher-
ent conditions (Figure 5B). To validate the results ob-
tained thus far using anti-active MAPK antibodies, we
also performed in vitro kinase assays on mitogen-
activated HUVECs. A typical experiment is illustrated
in Figure 5C using bFGF; similar results were also
found for EGF (our unpublished results). Thus, the
direct kinase assay parallels results with the anti-ac-
tive MAPK antibodies and demonstrates a strong an-
chorage dependence of polypeptide growth factor sig-
naling in HUVECs.
Other Agonists Known to Activate MAPK
Pathways also Require Adhesion to Fibronectin
We next decided to test whether other agonists known
to activate MAPK pathways might do so in an anchor-
age-dependent manner. In HUVECs, the neuropep-
tide bombesin, the bioactive lipid lysophosphatidic
acid (LPA), and the cytokine TNFa all activated
MAPK in an adhesion-dependent manner (Figure 6).
Although working by diverse mechanisms (Liu et al.,
1996; Della Roca et al., 1997), these signaling paths
were all modulated by integrin-mediated cell adher-
ence. Since TNF is thought to act more directly on the
JNK pathway rather than the “classic” MAPK path-
way, we decided to examine JNK activity to further
investigate the relationship between TNF signaling
and cell anchorage. Thus, a time course of JNK acti-
Figure 4. Anchorage dependence of EGF activation of MAPK.
Confluent ECV304 cells were serum starved for 6 to 8 h, trypsinized,
and suspended in medium containing 2% BSA. Following a 1-h
period in suspension, cells were allowed to adhere to dishes coated
with fibronectin or were held in suspension. Where indicated, EGF
was added to cells 5 min before harvest. Cells were lysed and
analyzed by Western blot analysis for MAPK activation. (A) EGF
dose response. Cells were treated with EGF (0–100 ng/ml) after
attachment to fibronectin (Fn), or after suspension culture (NAD),
for 3 h. Lysates were probed with an anti-active MAPK antibody.
(B) Time course. Cells were replated on a fibronectin substratum for
various periods of time and then treated with 1 ng/ml EGF (1) or
not (2). Top panel, anti-active MAPK Western blot. Bottom panel,
anti-MAPK Western blot.
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vation is shown in Figure 7A, while Figure 7B shows
the effects of increasing concentrations of TNFa. Equal
loading of JNK was demonstrated in both cases (our
unpublished results). As seen in Figure 7B, there was
very little activation of JNK in suspended cells treated
with TNFa, whereas even low concentrations of the
ligand produced robust activation in cells anchored on
fibronectin. A time course of JNK activation is shown
in Figure 7A. Taken together, these data suggest that
there might be a generalized influence of integrin-
mediated anchorage on MAPK pathways, including
the classic MAPK (or ERK) pathway, as well as the
related JNK pathway.
DISCUSSION
In this study, we examined whether cell anchorage
regulates growth factor signaling in endothelial cells
by comparing tyrosine phosphorylation events and
MAPK activation in adhesion- and growth factor-
stimulated cells. In addition to HUVECs, we used a
relatively recently described immortalized human en-
dothelial cell line, EVC304, as a model. Unlike primary
endothelial cells, ECV304 cells do not require special
growth factors, can be maintained in culture indefi-
nitely, and display markers characteristic for endothe-
lial cells (Takahashi et al., 1990). Both HUVECs and
ECV304 cells displayed typical “cobblestone” endo-
thelial morphologies and had well-developed focal
contacts and actin stress fibers. In addition, both dis-
played a complex repertoire of integrin subunits, in-
cluding substantial amounts of a5b1, a key fibronectin
receptor. Thus, both types of cells should be useful in
various aspects of studying integrin-mediated signal-
ing in endothelial-like cells.
As an initial approach to identifying signals acti-
vated by adhesion, we chose to examine tyrosine
phosphorylation events stimulated by adhesion in en-
dothelial cells and compared this to stimulation by
growth factors. In recent years, numerous studies
have reported on the tyrosine phosphorylation of cel-
lular components as a key transducer of inte-
grin-generated signaling pathways (Burridge et al.,
1992; Lin et al., 1995; Rosales et al., 1995). Consistent
with a recent report using NIH3T3 cells (Chen et al.,
1996), cell adhesion and growth factor stimulation
Figure 5. Mitogen-mediated activation of MAPK is anchorage de-
pendent in primary human endothelial cells (HUVECs). Confluent
HUVECs were serum starved for 8 h, trypsinized, and suspended in
medium containing 2% BSA. Following a 1-h period in suspension,
cells were allowed to adhere to dishes coated with fibronectin (Fn)
or held in suspension (NAD). In some cases, the cells were treated
for 5 min with bFGF or VEGF. Cells were washed and lysed, and
lysates were analyzed for MAPK activation. (A) Cells were main-
tained in suspension (2) or attached to fibronectin (1) for various
intervals, in the absence of growth factors, and the cell lysates were
probed with an anti-active MAPK antibody. (B) Cells were replated
on fibronectin (1) or held in suspension (2) for 3 h, and then
stimulated with either VEGF (20 ng/ml) or bFGF (10 ng/ml) or not
stimulated (CTL); cell lysates were probed with an anti-active
MAPK antibody. (C) Cells were replated on fibronectin (Fn) or held
in suspension (NAD) for 3 h, and then stimulated (1) with bFGF (10
ng/ml) or not stimulated (2); the cell lysates were analyzed using
an in vitro MAPK assay, as described in MATERIALS AND METH-
ODS. The autoradiogram represents the 32P phosphorylation of
MBP.
Figure 6. G protein-coupled receptor agonists and TNF-a show
anchorage-dependent activation of MAPK in HUVECs. Confluent
HUVECs were serum starved, trypsinized, and suspended in me-
dium containing 2% BSA. Following a 1-h period in suspension,
cells were allowed to adhere to dishes coated with fibronectin (Fn)
or held in suspension (NAD) for 3 h prior to agonist stimulation.
Cells were stimulated with either bombesin (Bom, 5 min, 10 nM),
LPA (5 min, 2 mM), or TNF-a (10 min, 10 ng/ml), and lysates were
analyzed by Western blotting. The top panel shows the activated
forms of MAPK using an anti-active MAPK antibody; the bottom
panel shows loading using an anti-MAPK antibody.
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triggered distinct initial tyrosine phosphorylation
events in endothelial cells. Tyrosine phosphorylation
of FAK and paxillin require anchorage to a matrix
substratum. Studies in fibroblasts show that phos-
phorylation of FAK on tyrosine 397 generates a site for
binding of the SH2 domain of src family kinases which
leads to further phosphorylation and recruitment of
SH2 proteins. It has also been reported that when
endothelial cells migrate into a wounded area on tis-
sue culture plastic, FAK tyrosine phosphorylation is
induced (Romer et al., 1994), suggesting an important
role for FAK in endothelial cell migration. In contrast,
treatment of endothelial cells with EGF caused recep-
tor autophosphorylation, independent of anchorage,
and stimulation with EGF did not enhance the adhe-
sion-mediated phosphorylation of either FAK or pax-
illin. We also show that treatment of cells with either
bFGF or VEGF induced receptor phosphorylation in
an anchorage-independent manner. Interestingly, an-
other group has found that VEGF caused tyrosine
phosphorylation of both FAK and paxillin in endothe-
lial cells (Abedi and Zachary, 1997). At present we
cannot account for this difference. In our studies, we
have consistently found that cell adhesion and growth
factor stimulation induce distinct upstream tyrosine
phosphorylation events.
MAPKs are key components of signaling pathways
downstream of a variety of cell surface receptors in-
cluding tyrosine kinase receptors, integrins, G protein-
coupled receptors, and perhaps by as yet not identi-
fied shear stress receptors (Miyasaka et al., 1990; Duff
et al., 1992; Chen et al., 1994; Karin, 1994; Schlaepfer et
al., 1994; Morino et al., 1995; Zhu and Assoian, 1995;
Arai and Escobedo, 1996; Jo et al., 1997). MAPKs phos-
phorylate and regulate key intracellular enzymes and
transcription factors required for cell cycle progres-
sion and cell proliferation. The pathways leading from
growth factor receptor activation via receptor tyrosine
kinases to MAPK have been relatively well character-
ized (Khosravi-Far and Der, 1994). MAPK has also
been shown to be stimulated by integrin activation,
although key signaling events upstream of MAPK are
still unclear, and differences in signaling cascades may
be cell-type specific (Chen et al., 1994; Schlaepfer et al.,
1994; Morino et al., 1995; Zhu and Assoian, 1995; Chen
et al., 1996). Consistent with studies using fibroblasts,
we show a transient anchorage-dependent activation
of MAPK in endothelial cells. We also see a more rapid
and robust activation of MAPK in HUVECs compared
with ECV304s. However, this may not be surprising,
since it is often observed that primary cells yield stron-
ger signals than established cell lines. Although we do
not know why anchorage-dependent MAPK activa-
tion is transient, it is plausible that the kinetics of
MAPK may be regulated by MAPK phosphatases
(Cook et al., 1997). Although activation of MAPK and
FAK both seem to be key early signaling events upon
integrin ligation, our data are consistent with studies
using other cell lines indicating that MAPK activation
and FAK phosphorylation, although both dependent
on adhesion, are nonetheless independent events (Lin
et al., 1997a). This is evidenced by their distinct time
courses of activation. MAPK activation is rapid and
transient and is simultaneous with initial anchorage of
cells to fibronectin prior to cell spreading, whereas
FAK shows a somewhat more delayed activation, is
much more persistent, and its activation is coincident
with cell spreading.
Recent studies in fibroblasts indicate that integrins
can cooperate with growth factor receptors to contrib-
ute to efficient intracellular signal transduction events,
including the activation of MAPKs (Miyamoto et al.,
1995, 1996; Lin et al., 1997b; Renshaw et al., 1997). Our
results suggest that integrin-mediated anchorage to
fibronectin also regulates growth factor signaling in
endothelial cells, as shown by enhanced activation of
MAPK by EGF and other peptide mitogens in an-
chored cells as compared with suspension culture
cells. Interestingly, the diminished signaling to MAPK
Figure 7. Activation of JNK is anchorage dependent in HUVECs.
Confluent HUVECs were serum starved, trypsinized, and sus-
pended in medium containing 2% BSA. Following a 1-h period in
suspension, cells were allowed to adhere to dishes coated with
either fibronectin (Fn) or held in suspension (NAD) for 3 h prior to
agonist stimulation. (A) TNFa time course. Following a 3-h period
of cells replated on fibronectin or held in suspension, cells were
treated with TNFa for various times (0–20 min). (B) TNFa dose
response. Cells were stimulated with TNFa (0–125 ng/ml) for 10
min. Cells were lysed, and cell lysates were analyzed using an in
vitro JNK assay, as described in MATERIALS AND METHODS. The
autoradiograms represent the 32P phosphorylation of the substrate
c-Jun.
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seen in suspension cells cannot be overcome by in-
creasing levels of growth factor, suggesting a reduced
maximal response rather than a shift in the dose-
response curve. Since initial activation and autophos-
phorylation of the EGF receptor is anchorage indepen-
dent, our observations suggest that anchorage permits
efficient coupling between upstream and downstream
components of the signaling cascade. In fibroblasts,
there are conflicting observations concerning the locus
in the receptor tyrosine kinase to MAPK signaling
pathway that is regulated by anchorage (Lin et al.,
1997b; Renshaw et al., 1997). In this study, we have not
attempted a full dissection of the signaling process but
report only on MAPK activation.
As cells go from suspension culture to an anchored
situation, two sets of events occur that affect MAPK.
First, as discussed above, there is a rapid direct adhe-
sion-mediated MAPK activation that peaks at 15–30
min and then declines. Second, the cells go from a
state of being refractory to growth factor activation of
MAPK to a state where growth factor activation of
MAPK is very efficient. This change begins at about 30
min after cell attachment and continues until well after
the initial burst of adhesion-dependent MAPK activity
is past. Thus, events relatively late in the cell adhesion
process seem to set the stage for efficient signaling
from receptor tyrosine kinases to MAPK.
It should be noted that anchorage to fibronectin
regulates growth factor signaling in HUVECs as well
as in the ECV304 endothelial cell line. Indeed, the
effects of anchorage seem stronger in the primary cell
type, perhaps because of more stringent control of
signaling events. Anchorage dependence is character-
istic not only of EGF signaling to MAPK, but also for
other growth factors that operate through receptor
tyrosine kinases, including VEGF and FGF. Thus, the
effects first noted with EGF in ECV304 cells seem to
have some generality for other polypeptide growth
factors.
Interestingly, mitogens that operate through recep-
tors other than receptor tyrosine kinases also seem to
have their signaling cascades modulated by cell an-
chorage. Tyrosine phosphorylation of several signal-
ing proteins has been linked to the action of mitogens
that operate through G protein-coupled receptors, in-
cluding the neuropeptide bombesin and the lipid me-
diator LPA (Jalink et al., 1994; Casamassima and
Rozengurt, 1997). In fibroblasts, tyrosine phosphory-
lation of FAK and paxillin has been shown to be
induced by LPA and bombesin (Seufferlein and Ro-
zengurt, 1994; Rankin et al., 1996), whereas LPA has
been shown to activate MAPK in a number of cell
types (Dikic et al., 1996; Cook et al., 1997; Della Roca et
al., 1997; Renshaw et al., 1997). At present, relatively
little is known about the signaling pathways that link
either the bombesin or LPA receptors to phosphory-
lation of MAPK. One possibility is that the known
anchorage regulation of phosphoinositol lipid forma-
tion may impact on such G protein-coupled signaling
pathways (McNamee et al., 1993); however, other pos-
sibilities also exist. Here, we present evidence that, in
endothelial cells, integrins may be involved in modu-
lating the pathway between these G protein-coupled
receptors and key downstream kinases associated
with cell proliferation and differentiation. We also re-
port that TNFa shows anchorage-dependent activa-
tion of MAPK. In vivo, TNF is a mediator of systemic
inflammation and immune responses (Vilcek and Lee,
1991). A major site of action of TNF for these effects is
the vascular endothelium, where it induces inflamma-
tory responses by enhancing adhesion molecule ex-
pression and cytokine secretion (Pober and Cotran,
1990; Grau and Lou, 1993). TNF can activate the ERK
MAPK cascade in some cells, but it more usually
triggers a parallel pathway that activates the p38 and
JNK kinases (Liu et al., 1996). Our data suggest that
TNF cascades are also influenced by inte-
grin-mediated cell adhesion. The finding that several
different types of agonists, each triggering distinct
upstream biochemical events, all display anchorage
dependence of MAPK pathways, suggests that an-
chorage regulates events at loci where these diverse
pathways converge.
Current observations indicate that integrin-
mediated cell anchorage plays an important role in the
regulation of signal transduction processes in endo-
thelial cells. In the case of growth factors that act
through receptor tyrosine kinases, integrin-mediated
anchorage does not affect the initial autophosphoryla-
tion of the receptor, but it does seem to regulate the
efficiency of signaling to downstream effectors such as
MAPK. Cell anchorage also modulates the activation
of MAPK by certain G protein-coupled receptors and
by TNF, suggesting a very general role for anchorage
in the regulation of cell signaling. It remains to be seen
whether specific integrins are involved in this process
and what the precise role of anchorage modulation of
signaling might be in the complex biology of endothe-
lial cells.
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